Henry J. Sutton

Henry J. Sutton

Auto-generated profile, based on publicly available information

Henry J. Sutton

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JLJeong Hyun Lee
Jeong Hyun Lee
HSHenry J. Sutton
Henry J. Sutton
CCChristopher A. Cottrell
Christopher A. Cottrell
IPIvy Phung
Ivy Phung
GOGabriel Ozorowski
Gabriel Ozorowski
SCShane Crotty
Shane Crotty

31 July 2024 in Nature
Verified
Journal Article
Closed access
PDF file
SRSydney I. Ramirez
Sydney I. Ramirez
FFFarhoud Faraji
Farhoud Faraji
LHL. Benjamin Hills
L. Benjamin Hills
PLPaul G. Lopez
Paul G. Lopez
BGBenjamin Goodwin
Benjamin Goodwin
SCShane Crotty
Shane Crotty

17 May 2024 in Science
Verified
Journal Article
Open access
JSJon M. Steichen
Jon M. Steichen
IPIvy Phung
Ivy Phung
ESEugenia Salcedo
Eugenia Salcedo
GOGabriel Ozorowski
Gabriel Ozorowski
JWJordan R. Willis
Jordan R. Willis
WSWilliam R Schief
William R Schief
Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo–electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.

31 July 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CFCamilla R. Fisher
Camilla R. Fisher
HSHenry J. Sutton
Henry J. Sutton
JKJoe A. Kaczmarski
Joe A. Kaczmarski
HMHayley A. McNamara
Hayley A. McNamara
BCBen Clifton
Ben Clifton
ICIan A. Cockburn
Ian A. Cockburn
The repeat region of the Plasmodium falciparum circumsporozoite protein (CSP) is a major vaccine antigen because it can be targeted by parasite neutralizing antibodies; however, little is known about this interaction. We used isothermal titration calorimetry, X-ray crystallography and mutagenesis-validated modeling to analyze the binding of a murine neutralizing antibody to Plasmodium falciparum CSP. Strikingly, we found that the repeat region of CSP is bound by multiple antibodies. This repeating pattern allows multiple weak interactions of single FAB domains to accumulate and yield a complex with a dissociation constant in the low nM range. Because the CSP protein can potentially cross-link multiple B cell receptors (BCRs) we hypothesized that the B cell response might be T cell independent. However, while there was a modest response in mice deficient in T cell help, the bulk of the response was T cell dependent. By sequencing the BCRs of CSP-repeat specific B cells in inbred mice we found that these cells underwent somatic hypermutation and affinity maturation indicative of a T-dependent response. Last, we found that the BCR repertoire of responding B cells was limited suggesting that the structural simplicity of the repeat may limit the breadth of the immune response. Vaccines aim to protect by inducing the immune system to make molecules called antibodies that can recognize molecules on the surface of invading pathogens. In the case of malaria, our most advanced vaccine candidates aim to promote the production of antibodies that recognize the circumsporozoite protein (CSP) molecule on the surface of the invasive parasite stage called the sporozoite. In this report we use X-ray crystallography to determine the structure of CSP-binding antibodies at the atomic level. We use other techniques such as isothermal titration calorimetry and structural modeling to examine how this antibody interacts with the CSP molecule. Strikingly, we found that each CSP molecule could bind 6 antibodies. This finding has implications for the immune response and may explain why high titers of antibody are needed for protection. Moreover, because the structure of the CSP repeat is quite simple we determined that the number of different kinds of antibodies that could bind this molecule are quite small. However a high avidity interaction between those antibodies and CSP can result from a process called affinity maturation that allows the body to learn how to make improved antibodies specific for pathogen molecules. These data show that while it is challenging for the immune system to recognize and neutralize CSP, it should be possible to generate viable vaccines targeting this molecule.

22 August 2025 in Science Immunology
Verified
Journal Article
Open access
KMKrystal M. Ma
Krystal M. Ma
HSHenry J. Sutton
Henry J. Sutton
PPPayal P. Pratap
Payal P. Pratap
JSJon M. Steichen
Jon M. Steichen
DCDiane Carnathan
Diane Carnathan
WSWilliam R Schief
William R Schief
An effective prophylactic HIV vaccine will likely need to induce broadly neutralizing antibodies (bnAbs). bnAbs to the Apex region of the HIV envelope glycoprotein (Env) are promising targets for vaccination because of their relatively low somatic hypermutation compared with other bnAbs. Most Apex bnAbs engage Env using an exceptionally long heavy-chain complementarity-determining region 3 (HCDR3) containing specific binding motifs, which reduces bnAb precursor frequency and makes priming of rare bnAb precursors a likely limiting step in the path to Apex bnAb induction. We found that adjuvanted protein or mRNA lipid nanoparticle (LNP) immunization of rhesus macaques with ApexGT6, an Env trimer engineered to bind Apex bnAb precursors, consistently induced Apex bnAb–related precursors with long HCDR3s bearing bnAb-like sequence motifs. Cryo–electron microscopy revealed that elicited Apex bnAb–related HCDR3s had structures combining elements of several prototype Apex bnAbs. These results achieve a critical HIV vaccine development milestone in outbred primates.

30 January 2023 in Nature
Verified
Journal Article
Closed access
PDF file
JLJeong Hyun Lee
Jeong Hyun Lee
HSHenry J. Sutton
Henry J. Sutton
CCChristopher A. Cottrell
Christopher A. Cottrell
IPIvy Phung
Ivy Phung
GOGabriel Ozorowski
Gabriel Ozorowski
SCShane Crotty
Shane Crotty